Vaccine safety: a case for synthetic vaccine formulations

'From manufacture to the end use, vaccines must follow a long journey though a well-controlled path, the failure of which may cause serious damage to their potency, and as a result, offer little or no protection.

Saved in:
Bibliographic Details
Published inExpert review of vaccines Vol. 2; no. 6; pp. 725 - 727
Main Author Koganty, Rao R
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 01.12.2003
Taylor & Francis
Subjects
Drug Industry
Humans
Reviews
vaccines
Vaccines, Synthetic - administration & dosage
Vaccines, Synthetic - adverse effects
Vaccines, Synthetic - immunology
Online AccessGet full text

Cover

More Information
Summary:'From manufacture to the end use, vaccines must follow a long journey though a well-controlled path, the failure of which may cause serious damage to their potency, and as a result, offer little or no protection.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1476-0584
1744-8395
DOI:10.1586/14760584.2.6.725